SEC Form 4 · accession 0001437749-16-035627
CervoMed Inc. · CRVO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark T Giles
Director
Period of report
Jul 21, 2016
Accepted (ET)
Jul 25, 2016 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053691
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $0.90 | Jul 21, 2016 | A | 58,473 | A | — | Jul 21, 2026 | Common Stock | 58,473 | 58,473 | D |
Explanation of responses
- F1Option will vest monthly in equal 1/36th increments until fully vested.